A.forall Announces Launch of a Generic Version of Pyridostigmine Bromide Syrup
MINNETONKA, Minn.--(BUSINESS WIRE)--Dec 11, 2023--
Source: eagletribune.com
Art Deas News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Art Deas. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Art Deas Today - Breaking & Trending Today
ImmuPharma : Phase 2/3 adaptive clinical trial of P140 (Lupuzor™) in Lupus to commence following FDA meeting
Phase 2/3 adaptive clinical trial of P140 in Lupus to commence following FDA meeting 19th June 2023 - 9:43 am ImmuPharma PLC , the specialist drug discovery and development... | June 19, 2023
Source: marketscreener.com
ImmuPharma PLC presses on with next phase of Lupuzor clinical trials
ImmuPharma PLC (AIM:IMM, OTC:IMMPF) is set to initiate a Phase 2/3 adaptive clinical trial for its P140 (Lupuzor) drug in systemic lupus erythematosus...
Source: proactiveinvestors.co.uk
AcelRx Pharmaceuticals Announces Divestment of DSUVIA® to Alora Pharmaceuticals
Agreement with Alora Pharmaceuticals provides AcelRx with 15% royalties on commercial sales, 75% royalties on Department of Defense (DoD) sales, up to $116.5...
Source: prnewswire.com
Alora Pharmaceuticals Celebrates Acquisition of Monarch Manufacturing Facility
/PRNewswire/ -- Alora Pharmaceuticals, LLC, is pleased to announce that its wholly owned subsidiary, Sovereign Pharmaceuticals, LLC, has acquired, through...
Source: prnewswire.com